{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:39:48Z","timestamp":1782603588744,"version":"3.54.5"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,4,15]]},"DOI":"10.2169\/internalmedicine.1289-18","type":"journal-article","created":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T18:03:29Z","timestamp":1555265009000},"page":"1167-1172","source":"Crossref","is-referenced-by-count":16,"title":["Hashimoto's Encephalopathy Presenting with Smoldering Limbic Encephalitis"],"prefix":"10.2169","volume":"58","author":[{"given":"Masahiro","family":"Nagano","sequence":"first","affiliation":[{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Yamada-Otani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kuzuya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Oita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shimizu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Faculty of Nursing and Social Welfare Sciences, Fukui Prefectural University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brain L. Hashimoto's disease and encephalopathy. Lancet 288: 512-514, 1966.","DOI":"10.1016\/S0140-6736(66)92876-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhou JY, Xu B, Lopes J, Blamoun J, Li L. Hashimoto encephalopathy: literature review. Acta Neurol Scand 135: 285-290, 2017.","DOI":"10.1111\/ane.12618"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ghika-Schmid F, Ghika J, Regli F, et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition? Mov Disord 11: 555-562, 1996.","DOI":"10.1002\/mds.870110511"},{"key":"4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12888-016-0897-3","volume":"16","author":"D Endres","year":"2016","unstructured":"4. Endres D, Perlov E, Stich O, Tebartz van Elst L. Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) presenting as major depression. BMC Psychiatry 16: 184, 2016.","journal-title":"BMC Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/1471-244X","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Galluzzi S, Geroldi C, Zanetti O, Frisoni GB. Hashimoto's encephalopathy in the elderly: relationship to cognitive impairment. J Geriatr Psychiatry Neurol 15: 175-179, 2002.","DOI":"10.1177\/089198870201500309"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Endres D, Perlov E, Riering AN, et al. Steroid-responsive chronic schizophreniform syndrome in the context of mildly increased antithyroid peroxidase antibodies. Front Psychiatry 8: 64, 2017.","DOI":"10.3389\/fpsyt.2017.00064"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of \u03b1-enolase in Hashimoto's encephalopathy. J Neuroimmunol 185: 195-200, 2007.","DOI":"10.1016\/j.jneuroim.2007.01.018"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kishitani T, Matsunaga A, Ikawa M, et al. Limbic encephalitis associated with anti-NH2-terminal of \u03b1-enolase antibodies: a clinical subtype of Hashimoto encephalopathy. Medicine (Baltimore) 96: e6181, 2017.","DOI":"10.1097\/MD.0000000000006181"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kanazawa K, Matsumoto R, Shimotake A, et al. Persistent frequent subclinical seizures and memory impairment after clinical remission in smoldering limbic encephalitis. Epileptic Disord 16: 312-317, 2014.","DOI":"10.1684\/epd.2014.0664"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakaoku Y, Maki T, Kanazawa K, et al. A case of smoldering anti-leucine-rich glioma-inactivated 1 (LGI1) antibody-associated limbic encephalitis with faciobrachial dystonic seizure. Clin Neurol 53: 706-711, 2012 (In Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.53.706"},{"key":"11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"11. Heine J, Pr\u00fcss H, Bartsch T, et al. Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function. Neuroscience 309: 68-83, 2015.","journal-title":"Neuroscience","ISSN":"https:\/\/id.crossref.org\/issn\/0306-4522","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 260: 2744-2753, 2013.","DOI":"10.1007\/s00415-013-7048-2"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Fakhoury T, Abou-Khalil B, Kessler RM. Limbic encephalitis and hyperactive foci on PET scan. Seizure 8: 427-430, 1999.","DOI":"10.1053\/seiz.1999.0333"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Barboriak DP, Edward R. Limbic imaging. Psychiatry interpers Biol Process 170: 1659-1660, 1998.","DOI":"10.2214\/ajr.170.6.9609193"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kassubek J, Juengling FD, Nitzsche EU, L\u00fccking CH. Limbic encephalitis investigated by 18FDG-PET and 3D MRI. J Neuroimage 11: 55-59, 2001.","DOI":"10.1111\/j.1552-6569.2001.tb00011.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mijajlovic M, Mirkovic M, Dackovic J, Zidverc-Trajkovic J, Sternic N. Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases. J Neurol Sci 288: 194-196, 2010.","DOI":"10.1016\/j.jns.2009.09.030"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 243: 585-593, 1996.","DOI":"10.1007\/BF00900946"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Segers K, Braconnier P, Corazza F, et al. Subacute cognitive deterioration with high serum anti-thyroid peroxidase antibodies: two cases and a plea for pragmatism. Psychogeriatrics 13: 175-179, 2013.","DOI":"10.1111\/psyg.12018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 261: 1695-1705, 2014.","DOI":"10.1007\/s00415-014-7408-6"},{"key":"21","unstructured":"21. Nicolas G, Brandon FP, Vincent A, et al. New-onset refractory status epilepticus. Neurology 85: 1604-1613, 2014."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Morbelli S, Arbizu J, Booij J, et al. The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis. Eur J Nucl Med Mol Imaging 44: 353-357, 2017.","DOI":"10.1007\/s00259-016-3589-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pari E, Rinaldi F, Premi E, et al. A follow-up 18F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis. J Neurol 261: 663-667, 2014.","DOI":"10.1007\/s00415-013-7228-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Endres D, Vry MS, Dykierek P, et al. Plasmapheresis responsive rapid onset dementia with predominantly frontal dysfunction in the context of Hashimoto's encephalopathy. Front Psychiatry 8: 1-7, 2017.","DOI":"10.3389\/fpsyt.2017.00212"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139: 1079-1093, 2016.","DOI":"10.1093\/brain\/aww012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR. LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure 50: 14-17, 2017.","DOI":"10.1016\/j.seizure.2017.05.017"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Santoro D, Colombo I, Ghione I, et al. Steroid-responsive Hashimoto encephalopathy mimicking Creutzfeldt-Jakob disease. Neurol Sci 32: 719-722, 2011.","DOI":"10.1007\/s10072-011-0610-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rodriguez AJ, Jicha GA, Steeves TDL, Benarroch EE, Westmoreland BF. EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy). J Clin Neurophysiol 23: 371-373, 2006.","DOI":"10.1097\/01.wnp.0000214542.21735.49"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Castillo PR, Boeve BF, Westmoreland BF, Scha B. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 114: 32-37, 2003.","DOI":"10.1016\/S1388-2457(02)00343-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL. Electroencephalographic findings in Hashimoto's encephalopathy. Neurology 45: 977-981, 1996.","DOI":"10.1212\/WNL.45.5.977"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Marshall GA, Doyle JJ. Long-term treatment of Hashimoto's encephalopathy. J Neuropsychiatry Clin Neurosci 18: 14-20, 2006.","DOI":"10.1176\/jnp.18.1.14"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 81: 1167-1169, 2010.","DOI":"10.1136\/jnnp.2009.178293"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lai M, Huijbers MGM, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9: 776-785, 2010.","DOI":"10.1016\/S1474-4422(10)70137-X"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/8\/58_1289-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T11:27:42Z","timestamp":1574508462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/8\/58_1289-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1289-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}